IP Library Patent Application 15555701
Patent Application
App. No. 15/555,701

PROCESSES FOR PREPARING FLUOROKETOLIDES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/555,701
Abstract

Processes and intermediates for preparing fluoroketolide compounds are described herein.

Claims (34)

1 . A process for preparing a fluoroketolide of formula (I)

the process comprising contacting a compound of the formula

with a fluorinating agent and an amine base; wherein

R 1 is H or acyl, or le is a monosaccharide, such as methylamino or dimethylamino containing monosaccharide;

V is CH 2 —N(R), C═Q or C═NQ 1 ; where Q is O or (NR, H); where R is hydrogen or optionally substituted alkyl; and Q 1 is hydroxy or a derivative thereof or amino or a derivative thereof; and

W 1 is hydroxy or a derivative thereof; and W 2 is H, or hydroxy or a derivative thereof; or W 1 and W 2 are taken together with the attached carbon atoms to form an oxygen and/or nitrogen containing heterocycle, each of which is optionally substituted.

2 . The process of claim 1 wherein the base is a cyclic amine base, a non-aromatic amine base, or an amine base with a conjugate acid pKa of at least about 11, or a combination of the foregoing.

3 . The process of claim 1 wherein the base is sterically hindered.

4 . The process of claim 1 wherein the base is a diamine.

5 . The process of claim 1 wherein the base includes at least one nitrogen that does not have a hydrogen.

6 . The process of claim 1 wherein the base includes at least one C=N group.

7 . The process of claim 1 wherein the base is DBN or DBU, or a combination thereof.

8 . The process of claim 1 wherein the fluorinating agent is selected from the group consisting of NFSi, Selectfluor, and F-TEDA, and combinations thereof

9 . The process of claim 1 wherein the compound of formula (I) is

or a salt thereof.

10 . The process of claim 1 wherein the compound of formula (I) is

or a salt thereof.

11 . The process of claim 1 wherein the compound of formula (I) is solithromycin or a salt thereof.

12 . The process of claim 1 wherein the starting compound is of the formula

or a salt thereof.

13 . The process of claim 1 claim 8 wherein the starting compound is of the formula

or a salt thereof.

14 . A process for preparing a compound of formula (I), the process comprising or further comprising contacting a compound of the formula (DM)

or a salt thereof, with a methylating agent; wherein:

R 1a is H or acyl;

V is CH 2 —N(R), C═Q or C═NQ 1 ; where Q is O or (NR, H); where R is hydrogen or optionally substituted alkyl; and Q 1 is hydroxy or a derivative thereof or amino or a derivative thereof;

W 1 is hydroxy or a derivative thereof; and W 2 is H, or hydroxy or a derivative thereof; or W 1 and W 2 are taken together with the attached carbon atoms to form an oxygen and/or nitrogen containing heterocycle, each of which is optionally substituted.

15 . The process of claim 14 wherein the compound of formula (DM) is

or a salt thereof.

16 . The process of claim 14 wherein the compound of formula (DM) is

or a salt thereof.

17 . A composition comprising solithromycin that is substantially free of desfluoro solithromycin or N-desmethyl solithromycin, or both.

18 . The composition of claim 17 wherein the composition is substantially free of N desmethyl solithromycin.

19 . The composition of claim 17 wherein the composition is substantially free of desfluoro solithromycin.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2019
From: CEMPRA PHARMACEUTICALS, INC.
To: TETARD, INC.
Reel/Frame 050056/0731 →
RELEASE OF SECURITY INTEREST Recorded Jun 4, 2019
From: CORTLAND CAPITAL MARKET SERVICES LLC
To: CEMPRA PHARMACEUTICALS, INC.
Reel/Frame 049363/0706 →